Emmaus Life's market value is the price at which a share of Emmaus Life trades on a public exchange. It measures the collective expectations of Emmaus Life Sciences investors about its performance. Emmaus Life is trading at 0.0139 as of the 9th of February 2026, a 4.14 percent decrease since the beginning of the trading day. The stock's open price was 0.0145. With this module, you can estimate the performance of a buy and hold strategy of Emmaus Life Sciences and determine expected loss or profit from investing in Emmaus Life over a given investment horizon. Check out Emmaus Life Correlation, Emmaus Life Volatility and Emmaus Life Performance module to complement your research on Emmaus Life.
It's important to distinguish between Emmaus Life's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Emmaus Life should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Emmaus Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Emmaus Life 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Emmaus Life's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Emmaus Life.
0.00
11/11/2025
No Change 0.00
0.0
In 3 months and 1 day
02/09/2026
0.00
If you would invest 0.00 in Emmaus Life on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Emmaus Life Sciences or generate 0.0% return on investment in Emmaus Life over 90 days. Emmaus Life is related to or competes with Gilead Sciences, Sanofi ADR, Amgen, Merck, and Novo Nordisk. Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatm... More
Emmaus Life Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Emmaus Life's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Emmaus Life Sciences upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Emmaus Life's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Emmaus Life's standard deviation. In reality, there are many statistical measures that can use Emmaus Life historical prices to predict the future Emmaus Life's volatility.
Emmaus Life appears to be out of control, given 3 months investment horizon. Emmaus Life Sciences secures Sharpe Ratio (or Efficiency) of 0.0774, which denotes the company had a 0.0774 % return per unit of risk over the last 3 months. By reviewing Emmaus Life's technical indicators, you can evaluate if the expected return of 0.68% is justified by implied risk. Please utilize Emmaus Life's Coefficient Of Variation of 934.54, downside deviation of 9.53, and Mean Deviation of 4.98 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Emmaus Life holds a performance score of 6. The firm shows a Beta (market volatility) of -2.69, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Emmaus Life are expected to decrease by larger amounts. On the other hand, during market turmoil, Emmaus Life is expected to outperform it. Please check Emmaus Life's total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to make a quick decision on whether Emmaus Life's price patterns will revert.
Auto-correlation
0.38
Below average predictability
Emmaus Life Sciences has below average predictability. Overlapping area represents the amount of predictability between Emmaus Life time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Emmaus Life Sciences price movement. The serial correlation of 0.38 indicates that just about 38.0% of current Emmaus Life price fluctuation can be explain by its past prices.
Correlation Coefficient
0.38
Spearman Rank Test
0.55
Residual Average
0.0
Price Variance
0.0
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Emmaus OTC Stock
Emmaus Life financial ratios help investors to determine whether Emmaus OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Emmaus with respect to the benefits of owning Emmaus Life security.